Literature DB >> 30309244

Association of Fatigue With TPH2 Genetic Polymorphisms in Women With Irritable Bowel Syndrome.

Claire J Han1, Monica E Jarrett2, Kevin C Cain3, Sangeun Jun4, Margaret M Heitkemper2.   

Abstract

Fatigue is the most common extraintestinal symptom in women with irritable bowel syndrome (IBS). Genetic polymorphisms of monoamines are associated with fatigue in many chronic diseases. In this pilot exploratory study, the primary aim was to determine whether genetic polymorphisms of tryptophan hydroxylase ( TPH1/TPH2), serotonin reuptake transporter ( SERT), or catechol-O-methyltransferase ( COMT) are associated with fatigue in women with IBS. Additionally, analysis explored whether these genetic associations with fatigue would be present when controlling for abdominal pain, psychological distress, feeling stressed, and sleepiness during the day. Secondary analysis of two randomized controlled trial baseline data sets in Caucasian women with IBS ( N = 185) was conducted. Participants kept a daily diary with one dimension (i.e., severity) for each of the 26 symptoms, including fatigue, for 28 days prior to randomization. DNA samples were tested for single-nucleotide polymorphisms (SNPs) of TPH1 (four SNPs) /TPH2 (one SNP), SERT (one SNP), and COMT (one SNP). Analysis of covariance was used to examine associations of percentage of diary days with moderate to very severe symptoms with genetic polymorphisms. Only one SNP, TPH2 rs4570625, was significantly associated with fatigue ( p = .005). T-allele (low functional) carriers of TPH2 (i.e., G/T or T/T genotypes) reported a greater percentage of days with moderate to very severe fatigue than G/G homozygotes ( p = .001). Reduced synthesis of tryptophan in the central nervous system may contribute to reports of fatigue in women with IBS. Understanding genetic risk factors for fatigue may elucidate preemptive strategies to reduce fatigue in individuals with IBS.

Entities:  

Keywords:  catechol-O-methyltransferase; fatigue; genetic polymorphisms; irritable bowel syndrome; serotonin reuptake transporter; tryptophan hydroxylase

Mesh:

Substances:

Year:  2018        PMID: 30309244      PMCID: PMC6700882          DOI: 10.1177/1099800418806055

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  7 in total

1.  Symptoms among emerging adults with inflammatory bowel disease: a descriptive study.

Authors:  Kendra Kamp; Sharon Dudley-Brown; Margaret Heitkemper; Gwen Wyatt; Barbara Given
Journal:  Res Nurs Health       Date:  2019-10-10       Impact factor: 2.228

2.  Bile Acids and Microbiome Among Individuals With Irritable Bowel Syndrome and Healthy Volunteers.

Authors:  Kendra J Kamp; Kevin C Cain; Angelita Utleg; Robert L Burr; Daniel Raftery; Ruth Ann Luna; Robert J Shulman; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2020-07-15       Impact factor: 2.522

3.  Establishing the Omics Nursing Science & Education Network.

Authors:  Lois A Tully; Kathleen A Calzone; Ann K Cashion
Journal:  J Nurs Scholarsh       Date:  2020-02-06       Impact factor: 3.928

4.  Association between polymorphisms in the serotonin transporter gene-linked polymorphic region and risk for irritable bowel syndrome in China: evidence based on a meta-analysis.

Authors:  Zhanbo Jia; Liping Wang; Bianfang Yu; Qinggang Li; Xin Dong
Journal:  J Int Med Res       Date:  2019-07-05       Impact factor: 1.671

5.  The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome.

Authors:  Tingting Zhao; Yiming Zhang; Joochul Lee; Angela R Starkweather; Erin E Young; Xiaomei Cong
Journal:  J Pers Med       Date:  2022-01-21

Review 6.  Extraintestinal manifestations in irritable bowel syndrome: A systematic review.

Authors:  Bodil Ohlsson
Journal:  Therap Adv Gastroenterol       Date:  2022-08-09       Impact factor: 4.802

7.  Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use.

Authors:  Kendra J Kamp; Claire Han; Robert J Shulman; Kevin C Cain; Pamela Barney; Mark R Opp; Lin Chang; Robert L Burr; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2020-07-17       Impact factor: 2.522

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.